Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Pierre Issa

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Cancer|July 12, 2008
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemHagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Feasibility of therapy with hypomethylating agents in patients with renal insufficiencyG Nicolas Batty, Hagop Kantarjian, Jean-Pierre Issa, et al.
Cancer|July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Epigenetics|February 19, 2016
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomasBrittany Kleb, Marcos R H Estécio, Jiexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesisEmile M Youssef, Dafna Lotan, Jean-Pierre Issa, et al.
Molecular Endocrinology (Baltimore, Md.)|February 11, 2012
DNA demethylation-dependent AR recruitment and GATA factors drive Rhox5 homeobox gene transcription in the epididymisAnjana Bhardwaj, Hye-Won Song, Marcy Beildeck, et al.
Cancer Research|July 23, 2003
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancersJiuhong Yuan, Robert Z Luo, Satoshi Fujii, et al.
British Journal of Haematology|July 22, 2014
A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndromeMark Kirschbaum, Ivana Gojo, Stuart L Goldberg, et al.
Cancer Research|November 29, 2012
A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task ForceStephan Beck, Bradley E Bernstein, Robert M Campbell, et al.
Nature Communications|December 16, 2017
Ezh2 phosphorylation state determines its capacity to maintain CD8<sup>+</sup> T memory precursors for antitumor immunityShan He, Yongnian Liu, Lijun Meng, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Cancer|July 12, 2008
Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemHagop Kantarjian, Susan O'Brien, Farhad Ravandi, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Feasibility of therapy with hypomethylating agents in patients with renal insufficiencyG Nicolas Batty, Hagop Kantarjian, Jean-Pierre Issa, et al.
Cancer|July 25, 2003
Results of decitabine (5-aza-2'deoxycytidine) therapy in 130 patients with chronic myelogenous leukemiaHagop M Kantarjian, Susan O'Brien, Jorge Cortes, et al.
Epigenetics|February 19, 2016
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomasBrittany Kleb, Marcos R H Estécio, Jiexin Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
Hypermethylation of the retinoic acid receptor-beta(2) gene in head and neck carcinogenesisEmile M Youssef, Dafna Lotan, Jean-Pierre Issa, et al.
Molecular Endocrinology (Baltimore, Md.)|February 11, 2012
DNA demethylation-dependent AR recruitment and GATA factors drive Rhox5 homeobox gene transcription in the epididymisAnjana Bhardwaj, Hye-Won Song, Marcy Beildeck, et al.
Cancer Research|July 23, 2003
Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancersJiuhong Yuan, Robert Z Luo, Satoshi Fujii, et al.
British Journal of Haematology|July 22, 2014
A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndromeMark Kirschbaum, Ivana Gojo, Stuart L Goldberg, et al.
Cancer Research|November 29, 2012
A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task ForceStephan Beck, Bradley E Bernstein, Robert M Campbell, et al.
Nature Communications|December 16, 2017
Ezh2 phosphorylation state determines its capacity to maintain CD8<sup>+</sup> T memory precursors for antitumor immunityShan He, Yongnian Liu, Lijun Meng, et al.
Pageof 10